Explore EATRIS as a companya patienta scientista policy-makera visitor Login
EATRIS becomes a member of the Personalized Medicine Coalition
Fingenious® – A digital gateway to Finnish biobanks and biomedical research
EATRIS will participate in four new H2020-funded initiatives starting in 2019
Biological and Medical Sciences Research Infrastructures (BMS RI) Strategy Board publishes joint statement advocating for coherent roadmapping process
Personalised medicine: EATRIS gearing up for a series of events this November
TRANSVAC Open Call for Vaccine Development Services
TRANSVAC2 call for training “Adjuvants and Vaccine Formulation”
Neuroimaging Webinar Series
Medical ERIC’s release a joint statement on Horizon Europe
EATRIS attending Healthy Measures Open Conference in Barcelona
European Commission launches a multi-stakeholder consultation to improve the clinical trials of advanced therapy medicinal products
Approval of the European Joint Programme on Rare Diseases Horizon2020 grant proposal
A new collaboration enables new cell therapy treatments for HUS patients
EATRIS Annual Report 2017
The future of Translational Medicine by Toni Andreu
A Retrospective look at EATRIS during its first 5 years
Successful RItrain Knowledge Exchange workshop hosted by EATRIS
Public consultation: Evaluation of the European Medicines Agency Fee System